Patent ID: 11945872
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. The antibody or antigen-binding fragment thereof of claim 12 comprising:
(a) a HCDR1 domain having the amino acid sequence of SEQ ID NO: 44;
(b) a HCDR2 domain having the amino acid sequence of SEQ ID NO: 46;
(c) a HCDR3 domain having the amino acid sequence of SEQ ID NO: 28;
(d) a LCDR1 domain having the amino acid sequence of SEQ ID NO: 50;
(e) a LCDR2 domain having the amino acid sequence of SEQ ID NO: 52; and
(f) a LCDR3 domain having the amino acid sequence of SEQ ID NO: 36.